API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/jongu-4308-issues-voluntary-nationwide-recall-of-hydro-pineapple-burn-due-to-the-presence-of-undeclared-sibutramine-1629189013.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dash-xclusive-issues-voluntary-nationwide-recall-imperia-elita-vitaccino-coffee-due-presence-0
https://www.pharmacompass.com/pdf/news/golean-detox-us-receives-fda-warning-letter-1557211140.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-21-2018-1542783991.pdf
https://www.pharmacompass.com/pdf/news/fat-burners-zone-issues-voluntary-nationwide-recall-of-zero-xtreme-1539751420.pdf
https://www.forbes.com/sites/joshuacohen/2018/09/10/belviq-study-results-may-improve-the-fortunes-of-weight-loss-drugs/#2cefd3836a40
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-14-2018-1521002669.pdf
http://portal.anvisa.gov.br/noticias/-/asset_publisher/FXrpx9qY7FbU/content/suspensao-de-lote-falsificado-de-sibutramina-biomag/219201?p_p_auth=cHmAbscc&inheritRedirect=false&redirect=http%3A%2F%2Fportal.anvisa.gov.br%2Fnoticias%3Fp_p_auth%3DcHmAbscc%26p_p_id%3D101_INSTANCE_FXrpx9qY7FbU%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3D_118_INSTANCE_dKu0997DQuKh__column-2%26p_p_col_count%3D2
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2017-1487758756.pdf
https://www.pharmacompass.com/pdf/news/anvisa-suspends-newton-everett-biotech-sibutramine-1475237049.pdf
https://www.pharmacompass.com/pdf/news/anvisa-suspended-ach-sas-generic-sibutramine-hydrochloride-1473939674.pdf
https://www.pharmacompass.com/pdf/news/anvisa-suspended-ach-sas-sibutramine-hydrochloride-omeprazole-1470379564.pdf
https://www.pharmacompass.com/pdf/news/dr-reddys-generic-palonosetron-hydrochloride-approved-in-us-1461414788.pdf
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/201616/anvisa+determina+apreensao+de+sibutramina+falsificada
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53996a-eng.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53415a-eng.php
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0994-2015&w=05132015&lang=eng
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0993-2015&w=05132015&lang=eng
http://www.fiercepharma.com/story/eisai-gets-ema-nod-lenvima-just-weeks-after-fda-approval/2015-03-27
http://www.medpagetoday.com/Endocrinology/Diabetes/50672?xid=nl_mpt_DHE_2015-03-27&eun=g655567d0r&userid=655567&mu_id=5789356
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/43557a-eng.php